News

The primary objective of the study is to assess the overall response rate to the combination of bavituximab with docetaxel, a chemotherapy drug commonly used in breast cancer.

The Phase I trial will assess the safety and tolerability of E10030, an anti-PDGF aptamer, in combination with an anti-VEGF agent. E10030 is the first of three compounds

Wockhardt received approval from the FDA for marketing the tablets containing 250mg, 500mg and 600mg azithromycin, which is used for treating various kinds of infections. Azithromycin is the

This file has been accepted for review by the European Medicines Agency (EMEA). Clinical trials, involving more than 7,000 adult or elderly participants, evaluated the safety and ability

The planned research, which will be conducted as part of BG Medicine’s High Risk Plaque (HRP) Initiative, will apply BG Medicine’s proprietary proteomic and metabolomic discovery platform capabilities.

Each unit will be comprised of one common share of the company and one half of one share purchase warrant. Each whole warrant will entitle the holder to

Altor plans on initiating a multi-center, Phase II clinical study later in 2008, using the lead therapeutic antibody known as ALT-836 for the treatment of acute respiratory distress

The suit seeks injunctive relief and damages for infringement of three of the Andersen family of patents for transcatheter heart valve technology. These patents relate to valve prosthesis

While all of KRIBB’s technologies will be considered for transfer into ‘NuCo’, those having the greatest potential for contributing to the discovery of drugs that address unmet medical